Status:
COMPLETED
Predicting Ventricular Tachyarrhythmias Following Acute ST Elevation Myocardial Infarction
Lead Sponsor:
Clinical Centre of Serbia
Conditions:
Risk Stratification
Eligibility:
All Genders
18+ years
Brief Summary
Predict-VT is an investigator-initiated, prospective, observational clinical trial. Four hundred patients with ST elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary...
Detailed Description
Study design Predict-VT is an investigator-initiated, prospective, open-label, single-center clinical trial. The research protocol has been approved by the Ethics Committee of the Clinical Center of S...
Eligibility Criteria
Inclusion
- 18 years and older
- willing consent in writing
- undergoing primary PCI for STEMI
Exclusion
- cardiogenic shock at admission,
- noncardiac conditions that could interfere with compliance with the protocol,
- coexisting conditions associated with a limited life expectancy in the follow-up period.
- Prior documented arrhythmias like atrial fibrillation or ventricular tachyarrhythmias,
- Permanent pacemaker implanted,
- Previous haemodynamically significant valvular abnormalities,
- Chest wall deformities disabling adequate echocardiographic examination.
Key Trial Info
Start Date :
January 9 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03263949
Start Date
January 9 2017
End Date
February 1 2023
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Centre of Serbia, Emergency Hospital
Belgrade, Serbia, 11000